{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:59:14Z","timestamp":1781650754037,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Exercise during cancer treatment has been proposed not only as supportive care but also as a biologically active intervention with potential systemic effects. Mechanistic studies suggest that exercise modulates immune function and induces systemic signaling through exerkines, which may influence responsiveness to cancer therapies. However, evidence regarding exercise effects on treatment delivery, such as relative dose intensity, treatment completion, and tumor response, remains limited and heterogeneous. This scoping review aimed to map and summarize existing literature on associations between exercise, treatment delivery, and tumor response outcomes, highlighting patterns and gaps that inform future research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched the PubMed\/MEDLINE, Cochrane Library, and Cumulative Index to Nursing and Allied Health Literature Complete databases from inception to November 6, 2025. Studies examining the association between exercise interventions and treatment-related outcomes in patients with cancer were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Following eligibility assessment, 23 studies comprising 31 exercise interventions were included. Most studies have focused on breast and colorectal cancers and spanned various treatment phases, ranging from neoadjuvant to adjuvant settings. Treatment-related outcomes most commonly reflected treatment delivery and tolerance (e.g., relative dose intensity, dose delay or reduction, and treatment completion). Moreover, tumor response outcomes were reported, including pathological complete response, tumor size, response according to RECIST, and downstaging. Exercise interventions commonly consisted of aerobic exercise alone or in combination with resistance training, were predominantly supervised, and were often prescribed at moderate-to-high intensities, with a frequency of three to four sessions per week. Associations with favorable treatment-related outcomes were more frequently reported for supervised, moderate-to-high intensity exercise; however, null findings were common across all outcomes and cancer types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Current evidence indicates an inconsistent association between exercise and selected treatment delivery and tumor response outcomes in patients with cancer, suggesting a potential, context-dependent role of exercise under specific conditions. Future studies should clearly differentiate among treatment tolerance, delivery, and tumor response outcomes and investigate whether\u2014and how\u2014exercise influences these outcomes across various cancer types and treatment phases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-15992-6","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:36:58Z","timestamp":1777009018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exercise during chemotherapy or chemoradiotherapy and treatment delivery and tumor response outcomes: a scoping review"],"prefix":"10.1186","volume":"26","author":[{"given":"Takuya","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Okayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack B.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"15992_CR1","doi-asserted-by":"publisher","first-page":"e1609","DOI":"10.1002\/onco.13822","volume":"26","author":"CM Nielson","year":"2021","unstructured":"Nielson CM, Bylsma LC, Fryzek JP, Saad HA, Crawford J. Relative dose intensity of chemotherapy and survival in patients with advanced stage solid tumor cancer: a systematic review and meta-analysis. Oncologist. 2021;26:e1609\u201318. https:\/\/doi.org\/10.1002\/onco.13822.","journal-title":"Oncologist"},{"key":"15992_CR2","doi-asserted-by":"publisher","first-page":"957135","DOI":"10.3389\/fonc.2022.957135","volume":"12","author":"KS Courneya","year":"2022","unstructured":"Courneya KS, Booth CM. Exercise as cancer treatment: a clinical oncology framework for exercise oncology research. Front Oncol. 2022;12:957135. https:\/\/doi.org\/10.3389\/fonc.2022.957135.","journal-title":"Front Oncol"},{"key":"15992_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1249\/JES.0000000000000373","volume":"54","author":"KH Schmitz","year":"2026","unstructured":"Schmitz KH, Rogers LQ. Translation of evidence to clinical practice for exercise oncology: an update from the moving through cancer initiative. Exerc Sport Sci Rev. 2026;54:3\u201314. https:\/\/doi.org\/10.1249\/JES.0000000000000373.","journal-title":"Exerc Sport Sci Rev"},{"key":"15992_CR4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1186\/s12885-023-11391-3","volume":"23","author":"A Ahmadi Hekmatikar","year":"2023","unstructured":"Ahmadi Hekmatikar A, Nelson A, Petersen A. Highlighting the idea of exerkines in the management of cancer patients with cachexia: novel insights and a critical review. BMC Cancer. 2023;23:889. https:\/\/doi.org\/10.1186\/s12885-023-11391-3.","journal-title":"BMC Cancer"},{"key":"15992_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/jncimonographs\/lgaf025","volume":"2025","author":"DA Galv\u00e3o","year":"2025","unstructured":"Galv\u00e3o DA, Courneya KS, Lucia A, May AM, Mustian K, Warner AB, et al. History informing the future of exercise oncology. J Natl Cancer Inst Monogr. 2025;2025:306\u201314. https:\/\/doi.org\/10.1093\/jncimonographs\/lgaf025.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"15992_CR6","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1177\/1534735418807555","volume":"17","author":"J Nakano","year":"2018","unstructured":"Nakano J, Hashizume K, Fukushima T, Ueno K, Matsuura E, Ikio Y, et al. Effects of aerobic and resistance exercises on physical symptoms in cancer patients: a meta-analysis. Integr Cancer Ther. 2018;17:1048\u201358. https:\/\/doi.org\/10.1177\/1534735418807555.","journal-title":"Integr Cancer Ther"},{"key":"15992_CR7","doi-asserted-by":"publisher","first-page":"CD007566","DOI":"10.1002\/14651858.CD007566.pub2","volume":"2012","author":"SI Mishra","year":"2012","unstructured":"Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, et al. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev. 2012;2012:CD007566. https:\/\/doi.org\/10.1002\/14651858.CD007566.pub2.","journal-title":"Cochrane Database Syst Rev."},{"key":"15992_CR8","doi-asserted-by":"publisher","first-page":"CD008465","DOI":"10.1002\/14651858.CD008465.pub2","volume":"2012","author":"SI Mishra","year":"2012","unstructured":"Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. 2012;2012:CD008465. https:\/\/doi.org\/10.1002\/14651858.CD008465.pub2.","journal-title":"Cochrane Database Syst Rev."},{"key":"15992_CR9","doi-asserted-by":"publisher","first-page":"e2457859","DOI":"10.1001\/jamanetworkopen.2024.57859","volume":"8","author":"RY Soong","year":"2025","unstructured":"Soong RY, Low CE, Ong V, Sim I, Lee C, Lee F, et al. Exercise interventions for depression, anxiety, and quality of life in older adults with cancer: a systematic review and meta-analysis. JAMA Netw Open. 2025;8:e2457859. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.57859.","journal-title":"JAMA Netw Open"},{"key":"15992_CR10","doi-asserted-by":"publisher","first-page":"153473542091746","DOI":"10.1177\/1534735420917462","volume":"19","author":"S Morishita","year":"2020","unstructured":"Morishita S, Hamaue Y, Fukushima T, Tanaka T, Fu JB, Nakano J. Effect of exercise on mortality and recurrence in patients with cancer: a systematic review and meta-analysis. Integr Cancer Ther. 2020;19:1534735420917462. https:\/\/doi.org\/10.1177\/1534735420917462.","journal-title":"Integr Cancer Ther"},{"key":"15992_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa2502760","volume":"393","author":"KS Courneya","year":"2025","unstructured":"Courneya KS, Vardy JL, O\u2019Callaghan CJ, Gill S, Friedenreich CM, Wong RKS, et al. Structured exercise after adjuvant chemotherapy for colon cancer. N Engl J Med. 2025;393:13\u201325. https:\/\/doi.org\/10.1056\/NEJMoa2502760.","journal-title":"N Engl J Med"},{"key":"15992_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.semradonc.2018.10.001","volume":"29","author":"KA Ashcraft","year":"2019","unstructured":"Ashcraft KA, Warner AB, Jones LW, Dewhirst MW. Exercise as adjunct therapy in cancer. Semin Radiat Oncol. 2019;29:16\u201324. https:\/\/doi.org\/10.1016\/j.semradonc.2018.10.001.","journal-title":"Semin Radiat Oncol"},{"key":"15992_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmet.2017.09.015","volume":"27","author":"P Hojman","year":"2018","unstructured":"Hojman P, Gehl J, Christensen JF, Pedersen BK. Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab. 2018;27:10\u201321. https:\/\/doi.org\/10.1016\/j.cmet.2017.09.015.","journal-title":"Cell Metab"},{"key":"15992_CR14","doi-asserted-by":"publisher","first-page":"1671244","DOI":"10.3389\/fonc.2026.1671244","volume":"16","author":"AA Hekmatikar","year":"2026","unstructured":"Hekmatikar AA, Agha-Alinejad H, Yousefi-Ahmadipour A, Shamsi MM, Daud DMA. Immuno-oncological effects of aerobic exercise combined with anti-PD-L1 antibody blockade in a murine breast cancer model. Front Oncol. 2026;16:1671244. https:\/\/doi.org\/10.3389\/fonc.2026.1671244.","journal-title":"Front Oncol"},{"key":"15992_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.6004\/jnccn.2009.0009","volume":"7","author":"GH Lyman","year":"2009","unstructured":"Lyman GH. Impact of chemotherapy dose intensity on cancer patient outcomes. J Natl Compr Canc Netw. 2009;7:99\u2013108. https:\/\/doi.org\/10.6004\/jnccn.2009.0009.","journal-title":"J Natl Compr Canc Netw"},{"key":"15992_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.critrevonc.2019.02.005","volume":"136","author":"KA Bland","year":"2019","unstructured":"Bland KA, Zadravec K, Landry T, Weller S, Meyers L, Campbell KL. Impact of exercise on chemotherapy completion rate: a systematic review of the evidence and recommendations for future exercise oncology research. Crit Rev Oncol Hematol. 2019;136:79\u201385. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.02.005.","journal-title":"Crit Rev Oncol Hematol"},{"key":"15992_CR17","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1200\/JCO.2006.08.2024","volume":"25","author":"KS Courneya","year":"2007","unstructured":"Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007;25:4396\u2013404. https:\/\/doi.org\/10.1200\/JCO.2006.08.2024.","journal-title":"J Clin Oncol"},{"key":"15992_CR18","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1200\/JCO.2014.59.1081","volume":"33","author":"H van Waart","year":"2015","unstructured":"van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33:1918\u201327. https:\/\/doi.org\/10.1200\/JCO.2014.59.1081.","journal-title":"J Clin Oncol"},{"key":"15992_CR19","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1200\/JCO.2008.20.0634","volume":"27","author":"KS Courneya","year":"2009","unstructured":"Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol. 2009;27:4605\u201312. https:\/\/doi.org\/10.1200\/JCO.2008.20.0634.","journal-title":"J Clin Oncol"},{"key":"15992_CR20","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1634\/theoncologist.2015-0178","volume":"20","author":"YJ Xu","year":"2015","unstructured":"Xu YJ, Cheng JCH, Lee JM, Huang PM, Huang GH, Chen CCH. A walk-and-eat intervention improves outcomes for patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy. Oncologist. 2015;20:1216\u201322. https:\/\/doi.org\/10.1634\/theoncologist.2015-0178.","journal-title":"Oncologist."},{"key":"15992_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1249\/MSS.0000000000000855","volume":"48","author":"JK Van Vulpen","year":"2016","unstructured":"Van Vulpen JK, Velthuis MJ, Steins Bisschop CN, Travier N, Van Den Buijs BJW, Backx FJG, et al. Effects of an exercise program in colon cancer patients undergoing chemotherapy. Med Sci Sports Exerc. 2016;48:767\u201375. https:\/\/doi.org\/10.1249\/MSS.0000000000000855.","journal-title":"Med Sci Sports Exerc"},{"key":"15992_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00384-017-2921-6","volume":"33","author":"H van Waart","year":"2018","unstructured":"van Waart H, Stuiver MM, van Harten WH, Geleijn E, de Maaker-Berkhof M, Schrama J, et al. Recruitment to and pilot results of the PACES randomized trial of physical exercise during adjuvant chemotherapy for colon cancer. Int J Colorectal Dis. 2018;33:29\u201340. https:\/\/doi.org\/10.1007\/s00384-017-2921-6.","journal-title":"Int J Colorectal Dis."},{"key":"15992_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2015.08.012","author":"SMH Alibhai","year":"2015","unstructured":"Alibhai SMH, Durbano S, Breunis H, Brandwein JM, Timilshina N, Tomlinson GA, et al. A phase II exercise randomized controlled trial for patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Res. 2015. https:\/\/doi.org\/10.1016\/j.leukres.2015.08.012.","journal-title":"Leuk Res"},{"key":"15992_CR24","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/jnci\/djt297","volume":"105","author":"KS Courneya","year":"2013","unstructured":"Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Friedenreich CM, Yasui Y, et al. Effects of exercise dose and type during breast cancer chemotherapy: Multicenter randomized trial. J Natl Cancer Inst. 2013;105:1821\u201332. https:\/\/doi.org\/10.1093\/jnci\/djt297.","journal-title":"J Natl Cancer Inst"},{"key":"15992_CR25","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1158\/0008-5472.CAN-21-1258","volume":"81","author":"L Yang","year":"2021","unstructured":"Yang L, Morielli AR, Heer E, Kirkham AA, Cheung WY, Usmani N, et al. Effects of exercise on cancer treatment efficacy: a systematic review of preclinical and clinical studies. Cancer Res. 2021;81:4889\u201395. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1258.","journal-title":"Cancer Res"},{"key":"15992_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.clcc.2021.05.004","volume":"20","author":"AR Morielli","year":"2021","unstructured":"Morielli AR, Usmani N, Boul\u00e9 NG, Severin D, Tankel K, Joseph K, et al. Feasibility, safety, and preliminary efficacy of exercise during and after neoadjuvant rectal cancer treatment: a phase II randomized controlled trial. Clin Colorectal Cancer. 2021;20:216\u201326. https:\/\/doi.org\/10.1016\/j.clcc.2021.05.004.","journal-title":"Clin Colorectal Cancer"},{"key":"15992_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4137\/BCBCR.S9221","volume":"6","author":"R Rao","year":"2012","unstructured":"Rao R, Cruz V, Peng Y, Harker-Murray A, Haley BB, Zhao H, et al. Bootcamp during neoadjuvant chemotherapy for breast cancer: a randomized pilot trial. Breast Cancer (Auckl). 2012;6:39\u201346. https:\/\/doi.org\/10.4137\/BCBCR.S9221.","journal-title":"Breast Cancer (Auckl)"},{"key":"15992_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/XEB.0000000000000277","volume":"19","author":"MDJ Peters","year":"2021","unstructured":"Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Implement. 2021;19:3\u201310. https:\/\/doi.org\/10.1097\/XEB.0000000000000277.","journal-title":"JBI Evid Implement"},{"key":"15992_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"key":"15992_CR30","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/cncr.35204","volume":"130","author":"BJ Caan","year":"2024","unstructured":"Caan BJ, Brown JC, Lee C, Binder AM, Weltzien E, Ross MC, et al. Effect of home-based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer: the FORCE randomized control trial. Cancer. 2024;130:1858\u201368. https:\/\/doi.org\/10.1002\/cncr.35204.","journal-title":"Cancer"},{"key":"15992_CR31","doi-asserted-by":"publisher","first-page":"10715","DOI":"10.1002\/cam4.5831","volume":"12","author":"M Potiaumpai","year":"2023","unstructured":"Potiaumpai M, Schleicher EA, Wang M, Campbell KL, Sturgeon K, Schmitz KH. Exercise during chemotherapy: friend or foe? Cancer Med. 2023;12:10715\u201324. https:\/\/doi.org\/10.1002\/cam4.5831.","journal-title":"Cancer Med"},{"key":"15992_CR32","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1200\/JCO.23.00871","volume":"41","author":"T Sanft","year":"2023","unstructured":"Sanft T, Harrigan M, McGowan C, Cartmel B, Zupa M, Li F-Y, et al. Randomized trial of exercise and nutrition on chemotherapy completion and pathologic complete response in women with breast cancer: the lifestyle, exercise, and nutrition early after diagnosis study. J Clin Oncol. 2023;41:5285\u201395. https:\/\/doi.org\/10.1200\/JCO.23.00871.","journal-title":"J Clin Oncol"},{"key":"15992_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13102-022-00420-6","volume":"14","author":"KM Sturgeon","year":"2022","unstructured":"Sturgeon KM, Smith AM, Federici EH, Kodali N, Kessler R, Wyluda E, et al. Feasibility of a tailored home-based exercise intervention during neoadjuvant chemotherapy in breast cancer patients. BMC Sports Sci Med Rehabil. 2022;14:31. https:\/\/doi.org\/10.1186\/s13102-022-00420-6.","journal-title":"BMC Sports Sci Med Rehabil"},{"key":"15992_CR34","doi-asserted-by":"publisher","unstructured":"Brouwer CG, Hartman YAW, Stelten S, Kenkhuis MF, van Lonkhuijzen LRCW, Kenter GG, et al. Effects of a combined exercise and dietary intervention on clinical outcomes in patients with ovarian cancer: The Physical Activity and Dietary intervention in OVArian cancer (PADOVA) randomized controlled trial. Int J Gynecol Cancer. 2025;:ijgc\u20132024\u2013005634;35:101856. https:\/\/doi.org\/10.1136\/ijgc-2024-005634.","DOI":"10.1136\/ijgc-2024-005634"},{"key":"15992_CR35","doi-asserted-by":"publisher","first-page":"101060","DOI":"10.1016\/j.jshs.2025.101060","volume":"14","author":"IH Mast","year":"2025","unstructured":"Mast IH, Gootjes EC, R\u00fctten H, den Hartogh MD, Brouwer CG, Nagtegaal ID, et al. Feasibility and clinical potential of exercise interventions during neoadjuvant chemoradiotherapy in patients with esophageal and rectal cancer. J Sport Health Sci. 2025;14:101060. https:\/\/doi.org\/10.1016\/j.jshs.2025.101060.","journal-title":"J Sport Health Sci"},{"key":"15992_CR36","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.3892\/etm.2019.7215","volume":"17","author":"S Liu","year":"2019","unstructured":"Liu S, Zhou L, An L. Implementation of comprehensive rehabilitation therapy in postoperative care of patients with cholangiocarcinoma and its impact on patients\u2019 quality of life. Exp Ther Med. 2019;17:2703\u20137. https:\/\/doi.org\/10.3892\/etm.2019.7215.","journal-title":"Exp Ther Med"},{"key":"15992_CR37","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.2147\/CMAR.S208754","volume":"11","author":"YJ Shim","year":"2019","unstructured":"Shim YJ, Kim HJ, Oh SC, Lee SI, Choi SW. Exercise during adjuvant treatment for colorectal cancer: treatment completion, treatment-related toxicities, body composition, and serum level of adipokines. Cancer Manag Res. 2019;11:5403\u201312. https:\/\/doi.org\/10.2147\/CMAR.S208754.","journal-title":"Cancer Manag Res"},{"key":"15992_CR38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5535\/arm.240072","volume":"49","author":"MJ Hong","year":"2025","unstructured":"Hong MJ, Lee YJ, Park JB, Woo SY, Lee S, Ko H, et al. Effects of home-based rehabilitation for patients with advanced lung cancer undergoing platinum-based chemotherapy: a randomized controlled trial. Ann Rehabil Med. 2025;49:164\u201374. https:\/\/doi.org\/10.5535\/arm.240072.","journal-title":"Ann Rehabil Med"},{"key":"15992_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/onco.13970","volume":"27","author":"MK Mikkelsen","year":"2022","unstructured":"Mikkelsen MK, Lund CM, Vinther A, Tolver A, Johansen JS, Chen I, et al. Effects of a 12-week multimodal exercise intervention among older patients with advanced cancer: results from a randomized controlled trial. Oncologist. 2022;27:67\u201378. https:\/\/doi.org\/10.1002\/onco.13970.","journal-title":"Oncologist"},{"key":"15992_CR40","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1158\/1078-0432.CCR-25-0416","volume":"31","author":"E Kjeldsted","year":"2025","unstructured":"Kjeldsted E, Ammitzb\u00f8ll G, L\u00e6nkholm A-V, Rasic D, Ceballos SG, J\u00f8rgensen LB, et al. Effects of supervised exercise during neoadjuvant chemotherapy on tumor response in patients with breast cancer (neo-train): a randomized controlled trial. Clin Cancer Res. 2025;31:4265\u201377. https:\/\/doi.org\/10.1158\/1078-0432.CCR-25-0416.","journal-title":"Clin Cancer Res"},{"key":"15992_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1634\/theoncologist.2019-0262","volume":"25","author":"S Mijwel","year":"2020","unstructured":"Mijwel S, Bolam KA, Gerrevall J, Foukakis T, Wengstr\u00f6m Y, Rundqvist H. Effects of exercise on chemotherapy completion and hospitalization rates: the OptiTrain breast cancer trial. Oncologist. 2020;25:23\u201332. https:\/\/doi.org\/10.1634\/theoncologist.2019-0262.","journal-title":"Oncologist"},{"key":"15992_CR42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/bjsports-2021-104243","volume":"56","author":"J Zylstra","year":"2022","unstructured":"Zylstra J, Whyte GP, Beckmann K, Pate J, Santaolalla A, Gervais-Andre L, et al. Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial. Br J Sports Med. 2022;56:402\u20139. https:\/\/doi.org\/10.1136\/bjsports-2021-104243.","journal-title":"Br J Sports Med"},{"key":"15992_CR43","doi-asserted-by":"publisher","first-page":"101064","DOI":"10.1016\/j.jshs.2025.101064","volume":"14","author":"ME Schmidt","year":"2025","unstructured":"Schmidt ME, Goldschmidt S, Kreutz C, M\u00fcller J, Schneeweiss A, May AM, et al. Effects of aerobic or resistance exercise during neoadjuvant chemotherapy on tumor response and therapy completion in women with breast cancer: the randomized controlled BENEFIT trial. J Sport Health Sci. 2025;14:101064. https:\/\/doi.org\/10.1016\/j.jshs.2025.101064.","journal-title":"J Sport Health Sci"},{"key":"15992_CR44","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","volume":"51","author":"KL Campbell","year":"2019","unstructured":"Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51:2375\u201390. https:\/\/doi.org\/10.1249\/MSS.0000000000002116.","journal-title":"Med Sci Sports Exerc"},{"key":"15992_CR45","doi-asserted-by":"publisher","first-page":"949021","DOI":"10.3389\/fspor.2022.949021","volume":"4","author":"R Bern\u00e1rdez-V\u00e1zquez","year":"2022","unstructured":"Bern\u00e1rdez-V\u00e1zquez R, Raya-Gonz\u00e1lez J, Castillo D, Beato M. Resistance training variables for optimization of muscle hypertrophy: an umbrella review. Front Sports Act Living. 2022;4:949021. https:\/\/doi.org\/10.3389\/fspor.2022.949021.","journal-title":"Front Sports Act Living"},{"key":"15992_CR46","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1200\/JCO.23.00058","volume":"41","author":"JA Lavery","year":"2023","unstructured":"Lavery JA, Boutros PC, Scott JM, Tammela T, Moskowitz CS, Jones LW. Pan-cancer analysis of postdiagnosis exercise and mortality. J Clin Oncol. 2023;41:4982\u201392. https:\/\/doi.org\/10.1200\/JCO.23.00058.","journal-title":"J Clin Oncol"},{"key":"15992_CR47","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.1007\/s00520-021-06171-3","volume":"29","author":"J Nakano","year":"2021","unstructured":"Nakano J, Fukushima T, Tanaka T, Fu JB, Morishita S. Physical function predicts mortality in patients with cancer: A systematic review and meta-analysis of observational studies. Support Care Cancer. 2021;29:5623\u201334. https:\/\/doi.org\/10.1007\/s00520-021-06171-3.","journal-title":"Support Care Cancer"},{"key":"15992_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/epirev\/mxx007","volume":"39","author":"P Cormie","year":"2017","unstructured":"Cormie P, Zopf EM, Zhang X, Schmitz KH. The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects. Epidemiol Rev. 2017;39:71\u201392. https:\/\/doi.org\/10.1093\/epirev\/mxx007.","journal-title":"Epidemiol Rev"},{"key":"15992_CR49","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12916-026-04669-3","volume":"24","author":"A Haussmann","year":"2026","unstructured":"Haussmann A, Schmidt ME, Goldschmidt S, Hiensch AE, Wiskemann J, Steindorf K. Effects of aerobic or resistance exercise on sleep and cancer-related fatigue in patients with breast cancer during or after neoadjuvant chemotherapy: A 3-arm randomized controlled trial. BMC Med. 2026;24:114. https:\/\/doi.org\/10.1186\/s12916-026-04669-3.","journal-title":"BMC Med"},{"key":"15992_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-09101-1","volume":"33","author":"CG Brouwer","year":"2025","unstructured":"Brouwer CG, Tusscher MRT, de Roos BM, Gootjes EC, Buffart TE, Versteeg KS, et al. Experiences of patients with metastatic colorectal cancer participating in a supervised exercise intervention during chemotherapy. Support Care Cancer. 2025;33:82. https:\/\/doi.org\/10.1007\/s00520-024-09101-1.","journal-title":"Support Care Cancer"},{"key":"15992_CR51","doi-asserted-by":"publisher","unstructured":"Voorn MJJ, Aerts LPA, Bootsma GP, Bezuidenhout JB, van Kampen-van den Boogaart VE, Bongers BC, et al. Associations of pretreatment physical status parameters with tolerance of concurrent chemoradiation and survival in patients with non-small cell lung cancer. Lung. 2021;199:223-34. https:\/\/doi.org\/10.1007\/s00408-021-00427-9.","DOI":"10.1007\/s00408-021-00427-9"},{"key":"15992_CR52","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ijrobp.2020.01.004","volume":"108","author":"W-C Chou","year":"2020","unstructured":"Chou W-C, Chang P-H, Chen P-T, Wang H-M, Yeh K-Y, Lu C-H, et al. Clinical significance of vulnerability assessment in patients with primary head and neck cancer undergoing definitive concurrent chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2020;108:602\u201311. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.01.004.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"15992_CR53","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00520-023-07968-0","volume":"31","author":"AM Lav\u00edn-P\u00e9rez","year":"2023","unstructured":"Lav\u00edn-P\u00e9rez AM, Collado-Mateo D, Abbasi S, Ferreira-J\u00fanior JB, Hekmatikar AHA. Effects of exercise on immune cells with tumor-specific activity in breast cancer patients and survivors: a systematic review and meta-analysis. Support Care Cancer. 2023;31:507. https:\/\/doi.org\/10.1007\/s00520-023-07968-0.","journal-title":"Support Care Cancer"},{"key":"15992_CR54","doi-asserted-by":"publisher","first-page":"e001872","DOI":"10.1136\/jitc-2020-001872","volume":"9","author":"MP Gustafson","year":"2021","unstructured":"Gustafson MP, Wheatley-Guy CM, Rosenthal AC, Gastineau DA, Katsanis E, Johnson BD, et al. Exercise and the immune system: Taking steps to improve responses to cancer immunotherapy. J Immunother Cancer. 2021;9:e001872. https:\/\/doi.org\/10.1136\/jitc-2020-001872.","journal-title":"J Immunother Cancer"},{"key":"15992_CR55","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.3390\/cancers14205039","volume":"14","author":"J Handford","year":"2022","unstructured":"Handford J, Chen M, Rai R, Moss CL, Enting D, Peat N, et al. Is there a role for exercise when treating patients with cancer with immune checkpoint inhibitors? A scoping review. Cancers (Basel). 2022;14:5039. https:\/\/doi.org\/10.3390\/cancers14205039.","journal-title":"Cancers (Basel)"},{"key":"15992_CR56","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/jcsm.12755","volume":"12","author":"Y Takenaka","year":"2021","unstructured":"Takenaka Y, Oya R, Takemoto N, Inohara H. Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: A meta-analysis. J Cachexia Sarcopenia Muscle. 2021;12:1122\u201335. https:\/\/doi.org\/10.1002\/jcsm.12755.","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15992-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:38:37Z","timestamp":1781649517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15992-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15992"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15992-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate were not required for this review. The protocol is registered in the Open Science Framework (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"723"}}